SCHEMBL30765722

SCHEMBL30765722

CC(C)[C@@H](Nc1cnc(-c2ccccc2F)n(CC(=O)OC(C)(C)C)c1=O)c1ccc2oc3ccccc3c2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 9/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 1/20 0.35
KDM4E B2RXH2 1/20 0.34
FPR2 P25090 1/20 0.34
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
JAK3 P52333 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31558585 0.90 ALDH1A1 (0.35) ELANEALDH1A1HPGDKDM4EJAK2
SCHEMBL30765975 0.90 ALDH1A1 (0.35) ELANEALDH1A1HPGDKDM4EJAK2
SCHEMBL30765745 0.89 ELANE (0.37) ELANEALDH1A1HPGDHSP90AA1HSP90AB1
SCHEMBL30765701 0.88 ALDH1A1 (0.35) ELANEALDH1A1HPGDKDM4EJAK2
SCHEMBL30765534 0.88 GAA (0.40) ELANEALDH1A1HPGDRXFP1GABRP
SCHEMBL30765672 0.87 ALDH1A1 (0.33) ELANEALDH1A1HPGDKDM4EJAK2
SCHEMBL30765963 0.84 GABRP (0.37) ELANEALDH1A1HPGDKDM4EJAK2
SCHEMBL30766068 0.82 GPR139 (0.34) ALDH1A1HPGDKDM4ENPSR1RXFP1
SCHEMBL30765703 0.82 ALDH1A1 (0.36) ALDH1A1HPGDKDM4EJAK2JAK1
SCHEMBL30765991 0.82 ELANE (0.42) ELANEALDH1A1KDM4EJAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568666-A1 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS Alexion Pharmaceuticals, Inc. (US) 2025-06-18 EP disclosed
WO-2024035686-A1 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2024-02-15 WO disclosed